AngioDynamics Inc (ANGO)
5.66
-0.06
(-1.05%)
USD |
NASDAQ |
Jul 02, 16:00
5.655
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics SG&A Expense (TTM): 145.48M for Feb. 29, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 145.48M |
November 30, 2023 | 143.74M |
August 31, 2023 | 145.83M |
May 31, 2023 | 144.25M |
February 28, 2023 | 145.67M |
November 30, 2022 | 140.56M |
August 31, 2022 | 137.01M |
May 31, 2022 | 133.75M |
February 28, 2022 | 128.77M |
November 30, 2021 | 128.24M |
August 31, 2021 | 124.35M |
May 31, 2021 | 117.22M |
February 28, 2021 | 110.70M |
November 30, 2020 | 113.22M |
August 31, 2020 | 114.93M |
May 31, 2020 | 116.50M |
February 29, 2020 | 119.34M |
November 30, 2019 | 115.31M |
August 31, 2019 | 112.72M |
May 31, 2019 | 111.73M |
February 28, 2019 | 106.87M |
November 30, 2018 | 105.50M |
August 31, 2018 | 103.48M |
May 31, 2018 | 104.10M |
February 28, 2018 | 104.26M |
Date | Value |
---|---|
November 30, 2017 | 105.00M |
August 31, 2017 | 105.80M |
May 31, 2017 | 106.00M |
February 28, 2017 | 109.33M |
November 30, 2016 | 110.72M |
August 31, 2016 | 112.87M |
May 31, 2016 | 114.32M |
February 29, 2016 | 116.19M |
November 30, 2015 | 114.61M |
August 31, 2015 | 114.11M |
May 31, 2015 | 112.38M |
February 28, 2015 | 113.55M |
November 30, 2014 | 114.42M |
August 31, 2014 | 112.95M |
May 31, 2014 | 112.21M |
February 28, 2014 | 108.00M |
November 30, 2013 | 105.42M |
August 31, 2013 | 103.52M |
May 31, 2013 | 102.31M |
February 28, 2013 | 97.80M |
November 30, 2012 | 93.47M |
August 31, 2012 | 88.36M |
May 31, 2012 | 83.54M |
February 29, 2012 | 81.38M |
November 30, 2011 | 80.05M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
110.70M
Minimum
Feb 2021
145.83M
Maximum
Aug 2023
128.30M
Average
128.24M
Median
Nov 2021
SG&A Expense (TTM) Benchmarks
Becton Dickinson & Co | 4.734B |
Outset Medical Inc | 137.84M |
Boston Scientific Corp | 5.339B |
Perspective Therapeutics Inc | 19.11M |
Xtant Medical Holdings Inc | 72.60M |